KENGREAL: payments to doctors
Payments that named KENGREAL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.1M
- Providers
- 10,648
- Transactions
- 25,716
- Average per transaction
- $120
The per-transaction average — $120 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,648 providers the average total is $289, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Chiesi USA, Inc. | $3,077,000 | 100.0% |